Association of clinical features with HLA in chronic pulmonary thromboembolism

European Respiratory Journal

Volumn 25, Issue 1, 2005, Pages 131-138

  Tanabe, N ^a   Kimura, A ^b   Amano, S ^a   Okada, O ^a   Kasahara, Y ^a   Tatsumi, K ^a   Takahashi, M ^b   Shibata, H ^b   Yasunami, M ^b   Kuriyama, T ^a  

^a CHIBA UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

HLA; Polymorphism; Pulmonary embolism; Pulmonary hypertension; Thromboembolic disease

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DP ANTIGEN; HLA DR ANTIGEN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; DNA FINGERPRINTING; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; HEART INDEX; HEREDITY; HLA SYSTEM; HLA TYPING; HUMAN; JAPAN; LUNG EMBOLISM; LUNG GAS EXCHANGE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY; SEX RATIO; UNITED STATES; VENOUS OXYGEN TENSION;

ADULT; AGE DISTRIBUTION; AGED; ALLELES; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; JAPAN; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROBABILITY; PULMONARY EMBOLISM; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 13444262455     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00042304     Document Type: Article

References (48)

1. Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1990; 81: 1735-1743.
2. Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001; 345: 1465-1472.
3. Nakamura M, Okada O, Sakuma M, et al. Incidence and clinical characteristics of chronic pulmonary thromboembolism in Japan compared to acute pulmonary embolism - results of multicenter registry of the Japanese society of pulmonary embolism research. Circ J 2002; 66: 257-260.
4. Tanabe N, Okada O, Nakagawa Y, et al. The efficacy of pulmonary thromboendarterectomy on long-term gas exchange. Eur Respir J 1997; 10: 2066-2072.
5. Kunieda T, Naito M, Ookubo S, Yoshioka K, Nakanishi N, Oobayashi Y. Clinical aspects and diagnosis of pulmonary thromboembolism. Jpn J Thorac Dis 1988; 26: 463-472.
6. Archibald CJ, Auger WR, Fedullo PF, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 1999; 160: 523-528.
7. Imanishi T, Akazawa T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991, vol 1. New York, Oxford University Press, 1992; pp. 1065-1220.
8. Kitamura H, Kobayashi Y, Kimura A, Numano F. Association of clinical manifestations with HLA-B alleles in Takayasu arteritis. Int J Cardiol 1998; 66: Suppl. 1, s121-s126.
9. Langevitz BYP, Buskila D, Gladman DD, Darlington GA, Farewell VT, Lee P. HLA alleles in systemic sclerosis: association with pulmonary hypertension. Br J Rheumatol 1992; 31: 609-613.
10. Mizuki N, Ota M, Katsuyama Y, et al. Association analysis between the MIC-A and HLA-B: alleles in Japanese patients with Behcet's disease. Arthritis Rheum 1999; 42: 1961-1966.
11. Barst RJ, Flaster ER, Menon A, Fotino M, Morse JH. Evidence for the association of unexplained pulmonary hypertension in children with the major histocompatibility complex. Circulation 1992; 85: 249-258.
12. Morse JH, Barst RJ, Itescu S, et al. Primary pulmonary hypertension in HIV infection: an outcome determined by particular HLA class II alleles. Am J Respir Crit Care Med 1996; 153: 1299-1301.
13. Morse JH, Barst RJ, Fotino M, et al. Primary pulmonary hypertension, tissue plasminogen activator antibodies, and HLA-DQ7. Am J Respir Crit Care Med 1997; 155: 274-278.
14. Tanabe N, Okada O, Abe Y, Masuda M, Nakajima N, Kuriyama T. The influence of fractional pulse pressure on the outcome of pulmonary thromboendarterectomy. Eur Respir J 2001; 17: 653-659.
15. Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology 1992; 182: 393-398.
16. Hugh-Jones P. A simple standard exercise test and its use for measuring exertion dyspnoea. BMJ 1952; 1: 65-71.
17. Terasaki PI. Microdroplet lymphocytotoxicity test. In: Ray JG, Hare DB, Pedersen PD, eds. Manual of tissue typing techniques. Bethesda, DHEW publications NO. (NIH) 76-545, 1976; pp. 69-80.
18. Yoshida M, Kimura A, Katsuragi K, Numano F, Sasazuki T. DNA typing of HLA-B gene in Takayasu's arteritis. Tissue Antigens 1993; 42: 87-90.
19. Dong RP, Kimura A, Numano F, Nishimura Y, Sasazuki T. HLA linked susceptibility and resistance to Takayasu arteritis. Heart Vessels 1992; 7: 73-80.
20. Kimura H, Okada O, Tanabe N, et al. Plasma MCP-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2001; 164: 319-324.
21. Kimura A, Kitamura H, Date Y, Numano F. Comprehensive analysis of HLA genes in Takayasu arteritis in Japan. Int J Cardiol 1996; 54: Suppl. s61-s69.
22. Auger WR, Permpikul P, Moser KM. Lupus anticoagulant, heparin use and thrombocytopenia in patients with chronic thromboembolic pulmonary hypertension: A preliminary report. Am J Med 1995; 99: 392.
23. Wolf M, Boyer-Neumann C, Parent F, et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J 2000; 15: 395-399.
24. Kumasaka N, Sakuma M, Shirato K. Incidence of pulmonary thromboembolism in Japan. Jpn Circ J 1999; 63: 439-441.
25. Murata M. Genetic polymorphisms associated with thrombotic disorders in the Japanese population. Fibrinolysis and Proteolysis 2000; 14: 155-164.
26. Riedel M, Ivaskova E, Sajdlova H. HLA and venous thromboembolism. Tissue Antigens 1981; 18: 280-281.
27. Sebastiani GD, Minisola G, Galeazzi M. HLA class II alleles and genetic predisposition to the antiphospholipid syndrome. Autoimmunity Reviews 2003; 2: 387-394.
28. Hashimoto H, Yamanaka K, Tokano Y, et al. HLA-DRB1 alleles and beta 2 glycoprotein I-dependent anticardiolipin antibodies in Japanese patients with systemic lupus erythematosus. Clin Ex Rheumatol 1998; 16: 423-427.
29. Morse JH, Barst RJ. Immunologic disturbances in primary pulmonary hypertension. Semin Respir Crit Care Med 1994; 15: 222-229.
30. Bonderman D, Turecek PL, Jakowitsch J, et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost 2003; 90: 372.
31. Lang IM, Bonderman D, Jakowitsch J, Skoro-Sajer N, Klepetko W, Kneussl M. Chronic thromboembolic pulmonary hypertension: update 2004. In: Demedts M, Delcroix M, Verhaeghe R, Verleden GM, eds. Pulmonary vascular pathology: A clinical update. Eur Respir Mon 2004: 27; 243-252.
32. Ames PR, Steuer A, Pap A, Denman AM. Thrombosis in Behcet's disease: a retrospective survey from a single UK center. Rheumatology 2001; 40: 652-655.
33. Hirsch AM, Moser KM, Auger WR, Channick RN, Fedullo PF. Unilateral pulmonary artery thrombotic occlusion: Is distal arteriopathy a consequence? Am J Respir Crit Care Med 1996; 154: 491-496.
34. Ishikawa K. Natural history and classification of occlusive thromboaortopathy. Circulation 1978; 58: 173-177.
35. Numano F. Hereditary factors of Takayasu arteritis. Heart Vessels 1992; Suppl. 7, 68-72.
36. Numano F, Isohisa I, Maezawa H, Juli H. HLA antigens in Takayasu arteritis. Am Heart J 1979; 98: 153-159.
37. Kimura A, Ota M, Katsuyama Y, et al. Mapping of the HLA-linked genes controlling the susceptibility to Takayasu's arteritis. Int J Cardiol 2000; 75: Suppl. 75, S105-S110.
38. Lupi HE, Sanchez TG, Horwitz S, Gutierrez FE. Pulmonary artery involvement in Takayasu's arteritis. Chest 1975; 67: 69-74.
39. Kerr KM, Auger WR, Fedullo PF, Channick RH, Yi ES, Moser KM. Large vessel arteritis mimicking chronic thromboembolic disease. Am J Respir Crit Care Med 1995; 152: 367-373.
40. Lie JT. Isolated pulmonary Takayasu arteritis: clinicopathologic characteristics. Mod Pathol 1996; 9: 469-474.
41. Roberts HC, Kauczor H-U, Schweden F, Thelen M. Spiral CT of pulmonary hypertension and chronic thromboembolism. J Thorac Imaging 1997; 12: 118-127.
42. Bergin CJ, Sirlin C, Deutsch R, et al. Predictors of patient response to pulmonary thromboendarterectomy. Am J Roentgenol 2000; 174: 509-515.
43. Thistlethwaite PA, Mo M, Madani MM, et al. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thoracic Cardiovasc Surg 2002; 124: 1203-1211.
44. Valdes AM, Noble JA, Genin E, Clerget-Darpoux F, Erlich HA, Thomson G. Modeling of HLA class II susceptibility to type 1 diabetes reveals an effect associated with DPB1. Genetic Epidemiology 2001; 21: 212-223.
45. Bugawan TL, Kliltz W, Alejandrino M, et al. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos. Tissue Antigens 2002; 59: 452-469.
46. Saito S, Ota S, Yamada E, Inoko H, Ota M. Allele frequencies and haplotypic associations defined by allelic DNA typing a HLA class I and II loci in the Japanese population. Tissue Antigens 2000; 56: 522-529.
47. Nakajima F, Nakamura J, Yokota T. Analysis of HLA haplotypes in Japanese, using high resolution allele typing. MHC 2001; 8: 1-32.
48. Sofer JA. Population genetics (Hardy-Weinberg equilibrium and factors affecting it). In: Emery AE, Rimoin DL, eds. Principles and practice of medical vol 1. Edinburgh, Churchill Livingstone 1990; pp. 121-132.